Income Statement
DYNE THERAPEUTICS, INC.
DYN
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - |
|
Operating Expenses
|
468.18 | 343.89 | 242.16 | 170.96 | 150.03 | 58.65 |
|
Research & Development
|
398.33 | 281.41 | 210.76 | 142.76 | 121.31 | 45.20 |
|
Selling, General & Administrative
|
69.85 | 62.48 | 31.40 | 28.20 | 28.72 | 13.45 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-468.18 | -343.89 | -242.16 | -170.96 | -150.03 | -58.65 |
|
Non-Operating Income
|
- | - | - | - | - | - |
|
Interest Income
|
29.86 | 26.92 | 7.64 | 2.92 | 0.74 | 0.06 |
|
Interest Expense
|
- | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
21.97 | 26.47 | 6.23 | 2.86 | 0.73 | -0.79 |
|
Income Before Tax
|
- | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-446.21 | -317.42 | -235.94 | -168.10 | -149.29 | -59.44 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-466.14 | -342.19 | -240.46 | -169.26 | -148.93 | -57.95 |
|
Earnings Per Share (Basic)
|
-3.47 | -3.37 | -3.95 | -3.23 | - | - |
|
Diluted EPS
|
-3.47 | -3.37 | -3.95 | -3.23 | - | - |
|
Weighted Average Shares
|
- | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
- | - | - | - | - | - |
|
Comprehensive Income
|
-445.75 | -317.41 | -235.37 | -168.40 | -149.53 | -59.46 |